SREBF1 and metabolic dysfunction-associated steatohepatitis: Pai et al. (2019) reported that the oral administration of 100 mg/kg chrysin to adult male Wistar rats brought about a reduced gene expression of SREBP-1 and an increase in expression of PPAR-α, thereby protecting the rats against NASH [27].